Case 27-2005: An 80-year-old man with fatigue, unsteady gait, and confusion

New England Journal of Medicine

Volumn 353, Issue 10, 2005, Pages 1042-1050

  Johnson, Richard T ^a   Gonzalez, R Gilberto ^b,c   Frosch, Matthew P ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HALOPERIDOL; HYDROCHLOROTHIAZIDE; LISINOPRIL; LORAZEPAM; OXCARBAZEPINE; QUETIAPINE; RIVASTIGMINE; PRION PROTEIN;

AGED; ANAMNESIS; ARTICLE; BRAIN SPONGIOSIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFUSION; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC IMAGING; FATIGUE; GAIT DISORDER; HUMAN; HYPERTENSION; INSOMNIA; LABORATORY TEST; MALE; PRIORITY JOURNAL; BRAIN; CHEMISTRY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; FATALITY; ISOLATION AND PURIFICATION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGED; AGED, 80 AND OVER; BRAIN; CONFUSION; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FATIGUE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PRPC PROTEINS; PRPSC PROTEINS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 24344471281     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc059024     Document Type: Article

References (26)

1. Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G. Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology 1999;52:205-8.
2. Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002;59:128-34.
3. Ukisu R, Kushihashi T, Kitanosono T, et al. Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol 2005;184:560-6.
4. Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994-2004.
5. Bernoulli CC, Masters CL, Gajdusek DC, Gibbs CJ Jr, Harris JO. Early clinical features of Creutzfeldt-Jakob disease (subacute spongiform encephalopathy). In: Prusiner SB, Hadlow WJ, eds. Slow transmissible diseases of the nervous system. Vol. 1. New York: Academic Press, 1979:229-41.
6. Zeidler M, Green A. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 protein analysis. Neurology 2004;63:410-1.
7. Erdtmann R, Sivitz LB, eds. Advancing prion science: guidance for the National Prion Research Program. Washington, D.C.: National Academies Press, 2004.
8. Brown P, Preece M, Brandel J-P, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-81.
9. Medori R, Tritschler H-J, LeBlanc A, et al. Fatal familial insomnia: a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992;326:444-9.
10. Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol 2003;2:167-76.
11. Mastrianni JA, Nixon R, Layzer R, et al. Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 1999;340:1630-8.
12. Scaravilli F, Cordery RJ, Kretzschmar H, et al. Sporadic fatal insomnia: a case study. Ann Neurol 2000;48:665-8.
13. Kawasaki K, Wakabayashi K, Kawakami A, et al. Thalamic form of Creutzfeldt-Jakob disease or fatal insomnia? Report of a sporadic case with normal prion protein genotype. Acta Neuropathol (Berl) 1997;93:317-22.
14. Will RG, Ward HJ. Clinical features of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004;284:121-32.
15. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
16. Case Records of the Massachusetts General Hospital (Case 46-1961). N Engl J Med 1961;264:1359-64.
17. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990;40:887-90.
18. Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986;315:997-1003.
19. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
20. Ironside JW, Head MW, Bell JE, McCardle L, Will RG. Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 2000;37:1-9.
21. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9.
22. Hilton DA, Sutak J, Smith MEF, et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004;57:300-2.
23. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
24. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003;66:213-39.
25. Ironside JW, Head MW. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004;284:133-59.
26. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.